| 000 | 03073nam a2200469 i 4500 | ||
|---|---|---|---|
| 999 |
_c382809 _d382809 |
||
| 001 | 382809 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102122018.0 | ||
| 006 | a|||| o|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220412s2022 si | o |||| 0|eng d | ||
| 020 | _a9789811687020 | ||
| 024 | 7 |
_a10.1007/978-981-16-8702-0 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQR360 _b2022 EB |
|
| 245 | 0 | 0 |
_aVirus Entry Inhibitors : _bStopping the Enemy at the Gate _cedited by Shibo Jiang, Lu Lu |
| 250 | _a1st edition 2022 | ||
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2022 |
|
| 300 | _a1 recurso en línea (X, 239 páginas) | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aAdvances in Experimental Medicine and Biology _x2214-8019 _v1366 |
|
| 505 | 0 | _aPeptide virus entry inhibitors: past, present and future -- Small-molecule virus entry inhibitors -- Human endogenous virus entry inhibitors -- Lipopeptide HIV entry inhibitors -- Peptide HIV entry inhibitors targeting gp41 NHR -- Small-molecule HIV entry inhibitors targeting gp41 MPER -- Small-molecule HIV entry inhibitors targeting CD4-binding site in gp120 -- Small-molecule HIV entry inhibitors targeting gp120 -- SARS-CoV, MERS-CoV, and pan-coronavirus entry inhibitors -- Hendra virus (HeV) and Nipah virus (NiV) entry inhibitors -- Ebola virus entry inhibitors -- Cyclo-peptide-based Ebola virus entry inhibitors -- Influenza virus entry inhibitors -- Parainfluenza virus entry inhibitors -- Zika virus entry inhibitors -- HBV entry inhibitors -- HBV and HDV entry inhibitors -- HCV entry inhibitors -- Protein-based HPV entry inhibitors. | |
| 520 | _aThis book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors. | ||
| 988 | _aSpringer_BiomedLife_2022 | ||
| 650 | 7 |
_2embne _9413113 _aVirología |
|
| 700 | 1 |
_aJiang, Shibo. _eeditor literario |
|
| 700 | 1 |
_aLu, Lu. _eeditor literario |
|
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811687013 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811687037 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811687044 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-8702-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b09/2022 _dz _eb _zSI |
||